Key trends for China investors

-- | 27/01/2021

Page 1 of 1

Holly Black: Welcome to Morningstar. I'm Holly Black. With me is Rebecca Jiang. She is Manager of the JPMorgan China Growth & Income Trust. Hello.

Rebecca Jiang: Good morning, Holly.

Black: So, it wasn't a great start to the year for China focused funds in 2020, but things really picked up and your trust performed particularly well. So, what went right for you?

Jiang: I think, you know, Covid while clearly was unexpected, has actually accelerated and magnified a lot of the existing trends in China. So, a couple of things, first of all, increased investments into the healthcare system and increasing public health awareness. Secondly, you know, the digitisation of people's life, not only to consumers, but also to corporates as well. And lastly, a key trend of import substitution, and the stronger gets stronger. So overall, you know, the Trust has been pre-positioned for a lot of those trends. And we continue to find new ideas along those lines.

Black: And do you think those themes will continue through 2021 or you're looking at different areas now.

Jiang: I think some of those are clearly structural. So, for example, take public health awareness as an example. You know, you're probably not aware that the flu vaccination in China is extremely low, was extremely low at 5 per cent. But this winter season, this flu season, has seen, you know, rising awareness, people's awareness, and increasing willingness to get vaccinated. And we believe that this, these things are structural, and it's going to stay for a long period of time. You know, other things like import substitution, for example. A lot of the local companies took the advantage of less supply chain disruption and has gained market share from multinational companies. And those are some of the trends that we believe will continue. Clearly, valuation has been quite different now versus 12 months ago, which is another thing that we need to take into consideration. But, you know, we do believe that a lot of the structural trends basically pre-existed before Covid and will continue to exist afterwards.

Black: And are there any headwinds on the horizon or areas where you're feeling more cautious?

Jiang: I think when investing in China, investors—one thing that investors should keep at the back of their mind is that the China equity stock market is really young. You know, we're talking about 30 years of history, it was only open to foreign investors in the last five years. So, the companies are less mature and so are the market participants. So naturally, there are a lot of volatilities, there will be a lot of volatilities involved. And, we do feel that, from a longer-term perspective, the market valuation still looks to long term investors, but certainly some part of market clearly has gotten more expensive. So, it is our view that for investors who want to get exposure to China, probably the best way is through active managers who can pick the right stock, and probably more importantly, use the market volatility as their friend.

Black: And I can't let you go without asking you what is the outlook from the China perspective with the incoming US President Joe Biden?

Jiang: I think I probably won't be able to speak on the Chinese people's behalf. But it seems that the consensus within China is that China-US decoupling would be a long-term trend, or at least will last for a prolonged period of time. So, the domestic policies emphasis has been pretty much now switched to boosting internal consumption, as well as increasing self-sufficiencies, particularly in key sectors like technology.

Black: Rebecca, thank you so much for your time. From Morningstar, I'm Holly Black.

Prem Icon Morningstar's Global Best Ideas list is out now. Morningstar Premium subscribers can view the list here.

Prem Icon See also Morningstar Guide to International Investing

This report appeared on www.morningstar.com.au 2022 Morningstar Australasia Pty Limited

© 2022 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written content of Morningstar. Any general advice or 'class service' have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/s/fsg.pdf. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782 ("ASXO"). The article is current as at date of publication.